Corpus Intelligence IC Memo — ST. PETERSBURG GENERAL 2026-04-26 12:35 UTC
IC Memo — ST. PETERSBURG GENERAL
Investment Committee Memorandum | FL | 168 beds | Grade D | EBITDA uplift $7.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. PETERSBURG GENERAL

CCN 100180 | PINELLAS, FL | 168 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ST. PETERSBURG GENERAL is a 168-bed community hospital in PINELLAS, FL with $102.6M in net patient revenue and a 25.9% operating margin. The hospital serves a payer mix of 23.3% Medicare, 0.0% Medicaid, and 76.7% commercial.

Thesis: Turnaround. Our ML models identify $7.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 25.9% to 33.3% (+736bps).

Net Revenue HCRIS$102.6M
Current EBITDA COMPUTED$26.6M
Operating Margin COMPUTED25.9%
Occupancy HCRIS39.5%
Revenue / Bed COMPUTED$611K
Net-to-Gross HCRIS6.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
124
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 25.9% places it above the state median. Among 124 size-comparable peers (84-336 beds), the median margin is 2.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (84-336), prioritizing same-state peers. 124 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. PETERSBURG GENERAL (Target)FL168$102.6M25.9%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
JOHNS HOPKINS ALL CHILDRENS HOFL259$584.5M-10.3%
HOLY CROSS HOSPITALFL286$566.3M-0.7%
ADVENTHEALTH DAYTONA BEACHFL330$532.7M-1.9%
CCF HOSPITAL - WESTONFL258$465.4M-3.8%
DELRAY MEDICAL CENTERFL324$453.3M12.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.2M+210bp18mo
Cost to Collect4.5%2.5%$2.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.2M+122bp9mo
Clean Claim Rate88.0%96.0%$66K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.2M
Cost to Collect
$2.1M
Denial Rate Reduction
$2.0M
A/R Days Reduction
$1.2M
Clean Claim Rate
$66K
Total EBITDA Uplift$7.6M
Current EBITDA$26.6M
+ RCM Uplift+$7.6M
Pro Forma EBITDA$34.2M
Current Margin25.9%
Pro Forma Margin33.3%
WC Released (1x)$3.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$40.9M$251.0M6.13x43.7%
Base (11x exit)10.0x11.0x$40.9M$289.4M7.07x47.9%
Bull Case9.0x11.0x$36.8M$327.6M8.90x54.8%
Bull (12x exit)9.0x12.0x$36.8M$368.2M10.00x58.5%
Bear Case11.0x10.0x$45.0M$199.9M4.44x34.8%
Bear (11x exit)11.0x11.0x$45.0M$234.5M5.21x39.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 124 hospitals with 84-336 beds
  • Same-state prioritization (n=125)
  • Comp margins: P25=-6.5% / P50=2.8% / P75=14.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.